Silverfin false false 30/04/2025 08/04/2024 30/04/2025 H E A Cook 14/05/2024 Z A Elkins 14/05/2024 Professor M L Green 23/10/2024 A Klodas 14/05/2024 F C Lowry 08/04/2024 H H Morgan 14/05/2024 P S Rawlinson 23/10/2024 E V Sadler 14/05/2024 Dr M E Tempest 08/04/2024 N B Thomas 08/04/2024 J Zemmel 08/04/2024 27 March 2026 The principal activity of the company was that of developing a product to assist carehomes with prescribing medication and caring for their patients. 15625852 2025-04-30 15625852 bus:Director1 2025-04-30 15625852 bus:Director2 2025-04-30 15625852 bus:Director3 2025-04-30 15625852 bus:Director4 2025-04-30 15625852 bus:Director5 2025-04-30 15625852 bus:Director6 2025-04-30 15625852 bus:Director7 2025-04-30 15625852 bus:Director8 2025-04-30 15625852 bus:Director9 2025-04-30 15625852 bus:Director10 2025-04-30 15625852 bus:Director11 2025-04-30 15625852 core:CurrentFinancialInstruments 2025-04-30 15625852 core:ShareCapital 2025-04-30 15625852 core:SharePremium 2025-04-30 15625852 core:RetainedEarningsAccumulatedLosses 2025-04-30 15625852 core:ComputerEquipment 2024-04-07 15625852 2024-04-07 15625852 core:ComputerEquipment 2025-04-30 15625852 bus:OrdinaryShareClass1 2025-04-30 15625852 bus:OrdinaryShareClass2 2025-04-30 15625852 bus:OrdinaryShareClass3 2025-04-30 15625852 bus:OrdinaryShareClass4 2025-04-30 15625852 2024-04-08 2025-04-30 15625852 bus:FilletedAccounts 2024-04-08 2025-04-30 15625852 bus:SmallEntities 2024-04-08 2025-04-30 15625852 bus:AuditExemptWithAccountantsReport 2024-04-08 2025-04-30 15625852 bus:PrivateLimitedCompanyLtd 2024-04-08 2025-04-30 15625852 bus:Director1 2024-04-08 2025-04-30 15625852 bus:Director2 2024-04-08 2025-04-30 15625852 bus:Director3 2024-04-08 2025-04-30 15625852 bus:Director4 2024-04-08 2025-04-30 15625852 bus:Director5 2024-04-08 2025-04-30 15625852 bus:Director6 2024-04-08 2025-04-30 15625852 bus:Director7 2024-04-08 2025-04-30 15625852 bus:Director8 2024-04-08 2025-04-30 15625852 bus:Director9 2024-04-08 2025-04-30 15625852 bus:Director10 2024-04-08 2025-04-30 15625852 bus:Director11 2024-04-08 2025-04-30 15625852 core:ComputerEquipment core:TopRangeValue 2024-04-08 2025-04-30 15625852 core:ComputerEquipment 2024-04-08 2025-04-30 15625852 bus:OrdinaryShareClass1 2024-04-08 2025-04-30 15625852 bus:OrdinaryShareClass2 2024-04-08 2025-04-30 15625852 bus:OrdinaryShareClass3 2024-04-08 2025-04-30 15625852 bus:OrdinaryShareClass4 2024-04-08 2025-04-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15625852 (England and Wales)

# CAREBRAIN LIMITED

### Unaudited Financial Statements
For the financial period from 08 April 2024 to 30 April 2025
Pages for filing with the registrar

CAREBRAIN LIMITED

## Unaudited Financial Statements

For the financial period from 08 April 2024 to 30 April 2025

Contents

CAREBRAIN LIMITED

## COMPANY INFORMATION

For the financial period from 08 April 2024 to 30 April 2025
CAREBRAIN LIMITED

## COMPANY INFORMATION (continued)

For the financial period from 08 April 2024 to 30 April 2025

Directors | H E A Cook (Appointed 14 May 2024)
| Z A Elkins (Appointed 14 May 2024)
| Professor M L Green (Appointed 23 October 2024)
| A Klodas (Appointed 14 May 2024)
| F C Lowry (Appointed 08 April 2024)
| H H Morgan (Appointed 14 May 2024)
| P S Rawlinson (Appointed 23 October 2024)
| E V Sadler (Appointed 14 May 2024)
| Dr M E Tempest (Appointed 08 April 2024)
| N B Thomas (Appointed 08 April 2024)
| J Zemmel (Appointed 08 April 2024)

Registered office | 6th Floor 9 Appold Street
| London
| EC2A 2AP
| United Kingdom

Company number | 15625852 (England and Wales)

Accountant | Kreston Reeves LLP
| Springfield House
| Springfield Road
| Horsham
| West Sussex
| RH12 2RG

CAREBRAIN LIMITED

## BALANCE SHEET

As at 30 April 2025
CAREBRAIN LIMITED

## BALANCE SHEET (continued)

As at 30 April 2025

| Note | 30.04.2025
|  | £
Fixed assets |  |
Tangible assets | 3 | 2,592
|  | 2,592
Current assets |  |
Debtors | 4 | 13,022
Cash at bank and in hand |  | 321,967
|  | 334,989
Creditors: amounts falling due within one year | 5 | ( 150,714)
Net current assets |  | 184,275
Total assets less current liabilities |  | 186,867
Net assets |  | 186,867
Capital and reserves |  |
Called-up share capital | 6 | 7,037
Share premium account |  | 764,678
Profit and loss account |  | ( 584,848 )
Total shareholders' funds |  | 186,867

For the financial period ending 30 April 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial period in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Carebrain Limited (registered number: 15625852) were approved and authorised for issue by the Board of Directors on 27 March 2026. They were signed on its behalf by:

A Klodas Director |

CAREBRAIN LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 08 April 2024 to 30 April 2025
CAREBRAIN LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 08 April 2024 to 30 April 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

##### General information and basis of accounting

Carebrain Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The companies registered number is 15625852. The address of the Company's registered office is 6th Floor, 9 Appold Street, London, EC2A 2AP, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial period. Differences between contributions payable in the financial period and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

##### Finance costs

Finance costs are charged to the Profit and Loss Account over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment | 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

##### Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

##### Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

##### Ordinary share capital

The ordinary share capital of the Company is presented as equity.

#### 2. Employees

| Period from 08.04.2024 to 30.04.2025
| Number
Monthly average number of persons employed by the Company during the period, including directors | 7

#### 3. Tangible assets

| Computer equipment |  | Total
| £ |  | £
Cost |  |  |
At 08 April 2024 | 0 |  | 0
Additions | 3,205 |  | 3,205
At 30 April 2025 | 3,205 |  | 3,205
Accumulated depreciation |  |  |
At 08 April 2024 | 0 |  | 0
Charge for the financial period | 613 |  | 613
At 30 April 2025 | 613 |  | 613
Net book value |  |  |
At 30 April 2025 | 2,592 |  | 2,592

#### 4. Debtors

| 30.04.2025
| £
Prepayments | 8,700
VAT recoverable | 4,322
| 13,022

#### 5. Creditors: amounts falling due within one year

| 30.04.2025
| £
Trade creditors | 111,931
Accruals | 2,100
Other taxation and social security | 9,379
Other creditors | 27,304
| 150,714

#### 6. Called-up share capital

| 30.04.2025
| £
Allotted, called-up and fully-paid |
204,599 Ordinary A shares of £ 0.01 each | 2,046
427,221 Ordinary B shares of £ 0.01 each | 4,272
71,500 Ordinary C shares of £ 0.01 each | 715
400 Ordinary shares of £ 0.01 each | 4
| 7,037

In the financial period 2025 class Ordinary shares were allotted with an aggregate nominal value of £4 and consideration of £4 was received.
In the financial period 2025 class Ordinary A shares were allotted with an aggregate nominal value of £2,046 and consideration of £249,996 was received.

In the financial period 2025 class Ordinary B shares were allotted with an aggregate nominal value of £4,272 and consideration of £521,000 was received.

In the financial period 2025 class Ordinary C shares were allotted with an aggregate nominal value of £715 and consideration of £715 was received.

#### 7. Financial commitments

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

The pension cost charge for the period represents contributions payable by the company to the fund and amounted to £6,508. Contributions totalling £2,304 were payable to the fund at the balance sheet date and is included in other creditors.